TheProfitWatch

TOVX - Theriva Biologics, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.21 0.0 (0.28%) 0.0 (0.0%) 0.0 (0.0%) 0.0 (0.99%) -0.01 (-3.2%) 0.0 (2.11%) 0.0 (1.57%) 0.0 (-1.9%)

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.93
Diluted EPS:
-1.93
Basic P/E:
-0.1106
Diluted P/E:
-0.1106
RSI(14) 1m:
45.83
VWAP:
0.21
RVol:

Events

Period Kind Movement Occurred At

Related News